Marijuana smoking is prevalent among HIV+ individuals, but its effects on pulmonary disease in the general population and people living with HIV remain unclear. This longitudinal prospective study examined the relationship between marijuana smoking, tobacco smoking, and pulmonary disease in HIV+ and HIV- men in the Multicenter AIDS Cohort Study.
1404 HIV+ and 1352 HIV- men with follow-up between 1996-2014 and ≥1 year self-reported marijuana and smoking exposure data from biannual study visits were included (age ≥30, ART use at baseline for HIV+ subjects). Infectious (influenza, bacterial and other pneumonia, tuberculosis) and non-infectious (chronic bronchitis, COPD, emphysema, lung cancer, pulmonary hypertension) events were assessed from self-report and ICD-9 codes. Cox regression was used to estimate the association between marijuana use and first incident infectious and non-infectious pulmonary diagnosis in models adjusted for tobacco smoking, age, race, education, years of follow-up, calendar year, CD4 count, and HIV viral load.
Median baseline age of participants was 43 years (IQR: 38-49); 69% were white, 82% had education >12 years, mean CD4 of HIV+ subjects was 454. 27% of HIV+ subjects reported ≥1 year of daily or weekly marijuana smoking, compared with 18% of HIV- subjects (p<0.001). During 25,788 person-years of follow-up, 407 HIV+ subjects had one or more infectious pulmonary diagnosis (27%, median follow-up 9 years), compared with 262 HIV- subjects (18%, median follow-up 11 years) (p<0.001), while non-infectious pulmonary diagnoses occurred at similar frequency between groups (19%, n=269 vs. 17%, n=232; p=0.19). Daily or weekly marijuana smoking in the prior 6 months was associated with higher adjusted hazard ratio (HR) for both infectious (HR 1.31, 95% CI 1.01-1.71) and non-infectious (HR 1.39, 95% CI 1.02-1.89) pulmonary diagnoses, independent of tobacco smoking and other risk factors. 2-year prior average marijuana use was associated with increased risk for both infectious and non-infectious pulmonary diagnoses when modeled as a continuous variable (HR 1.06, 95% CI 1.02-1.07, and HR 1.07, 95% CI 1.02-1.11, respectively, per 10 days use/month increase). There was no significant association between marijuana use and infectious or non-infectious events in HIV- participants.
Frequent marijuana smoking is a risk factor for infectious and non-infectious pulmonary disease in HIV-infected men, independent of tobacco smoking and other risk factors.